Skip to main content
SpringerLink
Log in

Melatonin in Healthy Aging and Longevity

  • Chapter
  • First Online:
Hormones in Ageing and Longevity

Part of the book series: Healthy Ageing and Longevity ((HAL,volume 6))

Abstract

Melatonin is a regulator of the circadian multioscillator system. It transmits the information ‘darkness’, contributes to internal and external alignment of rhythms and, presumably via sirtuin-1, to high amplitudes. During normal aging , both the circadian system and melatonin secretion deteriorate. These processes are aggravated by several diseases and disorders of different etiology, most strongly under conditions of neurodegeneration, especially Alzheimer’s disease. Preclinically, melatonin counteracts alterations that may contribute to the acceleration of aging. It supports mitochondrial electron flux, enhances intramitochondrial protection against free oxygen and nitrogen radicals, reduces the duration of permeability transition and attenuates free radical formation. In nontumor cells, it acts as an antiapoptotic agent and may prevent excessive peripheral mitophagy. Numerous preclinical studies have documented a remarkable neuroprotective potential. Despite encouraging results, the translation of findings to the human is sometimes problematic, e.g., because of the different association of melatonin with rest or activity in nocturnally active rodents and in man. These differences extend to the tractability of metabolic syndrome and diabetes type 2, because of the preferred times of food intake. An overexpressed risk allele of the melatonin receptor gene MTNR1B decreases glucose tolerance in humans. Insulin resistance is also of high interest to neuroinflammation. With regard to both pro- and antiinflammatory actions, the role of melatonin in human inflammaging remains to be clarified. Life extension by melatonin was only preclinically demonstrated and remained, in rodents, rather modest. In man, melatonin’s value should be sought in supporting healthy aging, which may have indirect effects on lifespan.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 169.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Abolhassani N, Leon J, Sheng Z, Oka S, Hamasaki H, Iwaki T, Nakabeppu Y (2017) Molecular pathophysiology of impaired glucose metabolism, mitochondrial dysfunction, and oxidative DNA damage in Alzheimer’s disease brain. Mech Ageing Dev 161(Pt A):95–104

    Google Scholar 

  • Acosta JC, Banito A, Wuestefeld T, Georgilis A, Janich P, Morton JP, Athineos D, Kang TW, Lasitschka F, Andrulis M, Pascual G, Morris KJ, Khan S, Jin H, Dharmalingam G, Snijders AP, Carroll AP, Capper D, Pritchard C, Inman GJ, Longerich T, Sansom OJ, Benitah SA, Zender L, Gil J (2013) A complex secretory program orchestrated by the inflammasome controls paracrine senescence. Nat Cell Biol 15(8):978–990

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Acuña-Castroviejo D, Escames G, López LC, Hitos AB, León J (2005) Melatonin and nitric oxide: two required antagonists for mitochondrial homeostasis. Endocrine 27(2):159–168

    Article  PubMed  Google Scholar 

  • Acuña-Castroviejo D, Escames G, Rodríguez MI, López LC (2007) Melatonin role in the mitochondrial function. Front Biosci 12:947–963

    Article  PubMed  Google Scholar 

  • Agil A, Navarro-Alarcón M, Ruiz R, Abuhamadah S, El-Mir MY, Vázquez GF (2011) Beneficial effects of melatonin on obesity and lipid profile in young Zucker diabetic fatty rats. J Pineal Res 50(2):207–212

    CAS  PubMed  Google Scholar 

  • Agil A, Rosado I, Ruiz R, Figueroa A, Zen N, Fernández-Vázquez G (2012) Melatonin improves glucose homeostasis in young Zucker diabetic fatty rats. J Pineal Res 52(2):203–210

    Article  CAS  PubMed  Google Scholar 

  • Andrabi SA, Sayeed I, Siemen D, Wolf G, Horn TF (2004) Direct inhibition of the mitochondrial permeability transition pore: a possible mechanism responsible for anti-apoptotic effects of melatonin. FASEB J 18(7):869–871

    CAS  PubMed  Google Scholar 

  • Andrabi SS, Parvez S, Tabassum H (2015) Melatonin and ischemic stroke: mechanistic roles and action. Adv Pharmacol Sci 2015:384750

    PubMed  PubMed Central  Google Scholar 

  • Anonmyous (2013) Low melatonin secretion is a risk factor for type 2 diabetes. BMJ 346:f2202

    Article  Google Scholar 

  • Arendt J, Skene DJ (2005) Melatonin as a chronobiotic. Sleep Med Rev 9(1):25–39

    Article  PubMed  Google Scholar 

  • Arlicot N, Tronel C, Bodard S, Garreau L, de la Crompe B, Vandevelde I, Guilloteau D, Antier D, Chalon S (2014) Translocator protein (18 kDa) mapping with [125I]-CLINDE in the quinolinic acid rat model of excitotoxicity: a longitudinal comparison with microglial activation, astrogliosis, and neuronal death. Mol Imaging 13:4–11

    PubMed  Google Scholar 

  • Armstrong SM, Redman JR (1991) Melatonin: a chronobiotic with anti-aging properties? Med Hypotheses 34(4):300–309

    Article  CAS  PubMed  Google Scholar 

  • Arrieta-Cruz I, Gutiérrez-Juárez R (2016) The role of insulin resistance and glucose metabolism dysregulation in the development of Alzheimer´s disease. Rev Invest Clin 68(2):53–58

    PubMed  Google Scholar 

  • Bellet MM, Orozco-Solis R, Sahar S, Eckel-Mahan K, Sassone-Corsi P (2011) The time of metabolism: NAD+, SIRT1, and the circadian clock. Cold Spring Harb Symp Quant Biol 76:31–38

    Article  CAS  PubMed  Google Scholar 

  • Bender Hoppe J, Frozza RL, Horn AP, Argenta Comiran R, Bernardi A, Campos MM, Oliveira Battastini AM, Salbego C (2010) Amyloid-β neurotoxicity in organotypic culture is attenuated by melatonin: involvement of GSK-3β, tau and neuroinflammation. J Pineal Res 48(3):230–238

    Article  CAS  Google Scholar 

  • Beni SM, Kohen R, Reiter RJ, Tan D-X, Shohami E (2004) Melatonin-induced neuroprotection after closed head injury is associated with increased brain antioxidants and attenuated late-phase activation of NF-kappaB and AP-1. FASEB J 18(1):149–151

    CAS  PubMed  Google Scholar 

  • Bonmati-Carrion MA, Alvarez-Sanchez N, Hardeland R, Madrid JA, Rol MA (2013) A comparison of B16 melanoma cells and 3T3 fibroblasts concerning cell viability and ROS production in the presence of melatonin, tested over a wide range of concentrations. Int J Mol Sci 14(2):3901–3920

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Brown GC (2007) Mechanisms of inflammatory neurodegeneration: iNOS and NADPH oxidase. Biochem Soc Trans 35(Pt 5):1119–1121

    Article  CAS  PubMed  Google Scholar 

  • Brown GC, Neher JJ (2010) Inflammatory neurodegeneration and mechanisms of microglial killing of neurons. Mol Neurobiol 41(2–3):242–247

    Article  CAS  PubMed  Google Scholar 

  • Bubenik GA, Konturek SJ (2011) Melatonin and aging: prospects for human treatment. J Physiol Pharmacol 62(1):13–19

    CAS  PubMed  Google Scholar 

  • Buffa S, Pellicanò M, Bulati M, Martorana A, Goldeck D, Caruso C, Pawelec G, Colonna-Romano G (2013) A novel B cell population revealed by a CD38/CD24 gating strategy: CD38–CD24– B cells in centenarian offspring and elderly people. Age (Dordr) 35(5):2009–2024

    Article  CAS  Google Scholar 

  • Cagnacci A, Cannoletta M, Renzi A, Baldassari F, Arangino S, Volpe A (2005) Prolonged melatonin administration decreases nocturnal blood pressure in women. Am J Hypertens 18(12, Pt 1):1614–1618

    Google Scholar 

  • Campuzano O, Castillo-Ruiz MM, Acarin L, Castellano B, Gonzalez B (2008) Distinct pattern of microglial response, cyclooxygenase-2, and inducible nitric oxide synthase expression in the aged rat brain after excitotoxic damage. J Neurosci Res 86(14):3170–3183

    Article  CAS  PubMed  Google Scholar 

  • Candore G, Caruso C, Colonna-Romano G (2010) Inflammation, genetic background and longevity. Biogerontology 11(5):565–573

    Article  CAS  PubMed  Google Scholar 

  • Cano Barquilla P, Pagano ES, Jiménez-Ortega V, Fernández-Mateos P, Esquifino AI, Cardinali DP (2014) Melatonin normalizes clinical and biochemical parameters of mild inflammation in diet-induced metabolic syndrome in rats. J Pineal Res 57(3):280–290

    Article  CAS  PubMed  Google Scholar 

  • Cardinali DP, Hardeland R (2017) Inflammaging, metabolic syndrome and melatonin: a call for treatment studies. Neuroendocrinology 104(4):382–397

    Google Scholar 

  • Cardinali DP, Bernasconi PA, Reynoso R, Toso CF, Scacchi P (2013) Melatonin may curtail the metabolic syndrome: studies on initial and fully established fructose-induced metabolic syndrome in rats. Int J Mol Sci 14(2):2502–2514

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Carrillo-Vico A, Lardone PJ, Álvarez-Sánchez N, Rodríguez-Rodríguez A, Guerrero JM (2013) Melatonin: buffering the immune system. Int J Mol Sci 14(4):8638–8683

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Cavallo A, Daniels SR, Dolan LM, Khoury JC, Bean JA (2004a) Blood pressure response to melatonin in type 1 diabetes. Pediatr Diabetes 5(1):26–31

    Article  PubMed  Google Scholar 

  • Cavallo A, Daniels SR, Dolan LM, Bean JA, Khoury JC (2004b) Blood pressure-lowering effect of melatonin in type 1 diabetes. J Pineal Res 36(4):262–266

    Article  CAS  PubMed  Google Scholar 

  • Chandrasekaran A, Ponnambalam G, Kaur C (2004) Domoic acid-induced neurotoxicity in the hippocampus of adult rats. Neurotox Res 6(2):105–117

    Article  PubMed  Google Scholar 

  • Chang H-C, Guarente L (2013) SIRT1 mediates central circadian control in the SCN by a mechanism that decays with aging. Cell 153(7):1448–1460

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Chang HM, Wu UI, Lan CT (2009) Melatonin preserves longevity protein (sirtuin 1) expression in the hippocampus of total sleep-deprived rats. J Pineal Res 47(3):211–220

    Article  CAS  PubMed  Google Scholar 

  • Cheng X, van Breemen RB (2005) Mass spectrometry-based screening for inhibitors of β-amyloid protein aggregation. Anal Chem 77(21):7012–7015

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Cheung RT (2003) The utility of melatonin in reducing cerebral damage resulting from ischemia and reperfusion. J Pineal Res 34(3):153–160

    Article  CAS  PubMed  Google Scholar 

  • Chuffa LG, Alves MS, Martinez M, Camargo IC, Pinheiro PF, Domeniconi RF, Júnior LA, Martinez FE (2016) Apoptosis is triggered by melatonin in an in vivo model of ovarian carcinoma. Endocr Relat Cancer 23(2):65–76

    Article  CAS  PubMed  Google Scholar 

  • Clark IA, Vissel B (2013) Treatment implications of the altered cytokine-insulin axis in neurodegenerative disease. Biochem Pharmacol 86(7):862–871

    Article  CAS  PubMed  Google Scholar 

  • Coppé JP, Patil CK, Rodier F, Sun Y, Muñoz DP, Goldstein J, Nelson PS, Desprez PY, Campisi J (2008) Senescence-associated secretory phenotypes reveal cell-nonautonomous functions of oncogenic RAS and p53 tumor suppressor. PLoS Biol 6(12):2853–2868

    Article  PubMed  CAS  Google Scholar 

  • Coppé JP, Desprez PY, Krtolica A, Campisi J (2010) The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu Rev Pathol 5:99–118

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Coto-Montes A, Boga JA, Rosales-Corral S, Fuentes-Broto L, Tan D-X, Reiter RJ (2012) Role of melatonin in the regulation of autophagy and mitophagy: a review. Mol Cell Endocrinol 361(1–2):12–23

    Article  CAS  PubMed  Google Scholar 

  • Cuesta S, Kireev R, Forman K, Garcia C, Escames G, Ariznavarreta C, Vara E, Tresguerres JAF (2010) Melatonin improves inflammation processes in liver of senescence-accelerated prone male mice (SAMP8). Exp Gerontol 45(12):950–956

    Article  CAS  PubMed  Google Scholar 

  • Cuesta S, Kireev R, García C, Forman K, Escames G, Vara E, Tresguerres JAF (2011) Beneficial effect of melatonin treatment on inflammation, apoptosis and oxidative stress on pancreas of a senescence accelerated mice model. Mech Ageing Dev 132(11–12):573–582

    Article  CAS  PubMed  Google Scholar 

  • Cuesta S, Kireev R, García C, Rancan L, Tresguerres JAF (2013) Melatonin can improve insulin resistance and aging-induced alterations in senescence-accelerated prone male mice (SAMP8). Age (Dordr) 35(3):659–671

    Article  CAS  Google Scholar 

  • Cutolo M, Maestroni GJM (2005) The melatonin-cytokine connection in rheumatoid arthritis. Ann Rheum Dis 64(8):1109–1111

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Das A, McDowell M, Pava MJ, Smith JA, Reiter RJ, Woodward JJ, Varma AK, Ray SK, Banik NL (2010) The inhibition of apoptosis by melatonin in VSC4.1 motoneurons exposed to oxidative stress, glutamate excitotoxicity, or TNF-alpha toxicity involves membrane melatonin receptors. J Pineal Res 48(2):157–169

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Davalos AR, Coppé JP, Campisi J, Desprez PY (2010) Senescent cells as a source of inflammatory factors for tumor progression. Cancer Metastasis Rev 29(2):273–283

    Article  PubMed  PubMed Central  Google Scholar 

  • De Felice FG, Lourenco MV, Ferreira ST (2014) How does brain insulin resistance develop in Alzheimer’s disease? Alzheimers Dement 10. Suppl 1:S26–S32

    Google Scholar 

  • de la Monte SM (2014a) Relationships between diabetes and cognitive impairment. Endocrinol Metab Clin North Am 43(1):245–267

    Article  PubMed  Google Scholar 

  • de la Monte SM (2014b) Type 3 diabetes is sporadic Alzheimer׳s disease: mini-review. Eur Neuropsychopharmacol 24(12):1954–1960

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • de la Monte SM, Tong M (2014) Brain metabolic dysfunction at the core of Alzheimer’s disease. Biochem Pharmacol 88(4):548–559

    Article  PubMed  CAS  Google Scholar 

  • DelaRosa O, Pawelec G, Peralbo R, Wikby A, Mariani E, Mocchegiani E, Tarazona R, Solana R (2006) Immunological biomarkers of ageing in man: changes in both innate and adaptive immunity are associated with health and longevity. Biogerontology 7(5–6):471–481

    Article  CAS  PubMed  Google Scholar 

  • Deng YQ, Xu GG, Duan P, Zhang Q, Wang JZ (2005) Effects of melatonin on wortmannin-induced tau hyperphosphorylation. Acta Pharmacol Sin 26(5):519–526

    Article  CAS  PubMed  Google Scholar 

  • Deng WG, Tang ST, Tseng HP, Wu KK (2006) Melatonin suppresses macrophage cyclooxygenase-2 and inducible nitric oxide synthase expression by inhibiting p52 acetylation and binding. Blood 108(2):518–524

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Devore EE, Harrison SL, Stone KL, Holton KF, Barrett-Connor E, Ancoli-Israel S, Yaffe K, Ensrud K, Cawthon PM, Redline S, Orwoll E, Schernhammer ES; Osteoporotic Fractures in Men (MrOS) Study Research Group (2016) Association of urinary melatonin levels and aging-related outcomes in older men. Sleep Med 23:73–80

    Google Scholar 

  • Dumbell R, Matveeva O, Oster H (2016) Circadian clocks, stress, and immunity. Front Endocrinol (Lausanne) 7:37

    Google Scholar 

  • Eckel RH, Depner CM, Perreault L, Markwald RR, Smith MR, McHill AW, Higgins J, Melanson EL, Wright KP Jr (2015) Morning circadian misalignment during short sleep duration impacts insulin sensitivity. Curr Biol 25(22):3004–3010

    Article  CAS  PubMed  Google Scholar 

  • Entrena A, Camacho ME, Carrión MD, López-Cara LC, Velasco G, León J, Escames G, Acuña-Castroviejo D, Tapias V, Gallo MA, Vivo A, Espinosa A (2005) Kynurenamines as neural nitric oxide synthase inhibitors. J Med Chem 48(26):8174–8181

    Article  CAS  PubMed  Google Scholar 

  • Eşrefoğlu M, Gül M, Ateş B, Erdoğan A (2011) The effects of caffeic acid phenethyl ester and melatonin on age-related vascular remodeling and cardiac damage. Fundam Clin Pharmacol 25(5):580–590

    Article  PubMed  CAS  Google Scholar 

  • Favero G, Stacchiotti A, Castrezzati S, Bonomini F, Albanese M, Rezzani R, Rodella LF (2015) Melatonin reduces obesity and restores adipokine patterns and metabolism in obese (ob/ob) mice. Nutr Res 35(10):891–900

    Article  CAS  PubMed  Google Scholar 

  • Feng Z, Chang Y, Cheng Y, Zhang BL, Qu ZW, Qin C, Zhang JT (2004) Melatonin alleviates behavioral deficits associated with apoptosis and cholinergic system dysfunction in the APP 695 transgenic mouse model of Alzheimer’s disease. J Pineal Res 37(2):129–136

    Article  CAS  PubMed  Google Scholar 

  • Ferreira ST, Clarke JR, Bomfim TR, De Felice FG (2014) Inflammation, defective insulin signaling, and neurological dysfunction in Alzheimer’s disease. Alzheimers Dement 10(1):S76–S83

    Google Scholar 

  • Forman K, Vara E, García C, Kireev R, Cuesta S, Acuña-Castroviejo D, Tresguerres JAF (2010) Beneficial effects of melatonin on cardiological alterations in a murine model of accelerated aging. J Pineal Res 49(3):312–320

    Article  CAS  PubMed  Google Scholar 

  • Forman K, Vara E, García C, Kireev R, Cuesta S, Escames G, Tresguerres JAF (2011) Effects of combined treatment with growth hormone and melatonin in the cardiological aging on male SAMP8 mice. J Gerontol A Biol Med Sci 66(8):823–834

    Article  CAS  Google Scholar 

  • Garaulet M, Gómez-Abellán P, Rubio-Sastre P, Madrid JA, Saxena R, Scheer FA (2015) Common type 2 diabetes risk variant in MTNR1B worsens the deleterious effect of melatonin on glucose tolerance in humans. Metabolism 64(12):1650–1657

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • García-Mauriño S, Pozo D, Carrillo-Vico A, Calvo JR, Guerrero JM (1999) Melatonin activates Th1 lymphocytes by increasing IL-12 production. Life Sci 65(20):2143–2150

    Article  PubMed  Google Scholar 

  • García-Mesa Y, Giménez-Llort L, López LC, Venegas C, Cristòfol R, Escames G, Acuña-Castroviejo D (2012) Melatonin plus physical exercise are highly neuroprotective in the 3×Tg-AD mouse. Neurobiol Aging 33(6):1124.e13–e29

    Google Scholar 

  • Geiger SS, Fagundes CT, Siegel RM (2015) Chrono-immunology: progress and challenges in understanding links between the circadian and immune systems. Immunology 146(3):349–358

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Golombek DA, Pandi-Perumal SR, Brown GM, Cardinali DP (2015) Some implications of melatonin use in chronopharmacology of insomnia. Eur J Pharmacol 762:42–48

    Article  CAS  PubMed  Google Scholar 

  • Gonzales-Portillo GS, Lozano D, Aguirre D, Reyes S, Borlongan CV, Tajiri N, Kaneko Y (2015) An update on the use of melatonin as a stroke therapeutic. Minerva Med 106(3):169–175

    CAS  PubMed  Google Scholar 

  • Goyal A, Terry PD, Superak HM, Nell-Dybdahl CL, Chowdhury R, Phillips LS, Kutner MH (2014) Melatonin supplementation to treat the metabolic syndrome: a randomized controlled trial. Diabetol Metab Syndr 6:124

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Grossman E, Laudon M, Yalcin R, Zengil H, Peleg E, Sharabi Y, Kamari Y, Shen-Orr Z, Zisapel N (2006) Melatonin reduces night blood pressure in patients with nocturnal hypertension. Am J Med 119(10):898–902

    Article  CAS  PubMed  Google Scholar 

  • Guenther AL, Schmidt SI, Laatsch H, Fotso S, Ness H, Ressmeyer A-R, Poeggeler B, Hardeland R (2005) Reactions of the melatonin metabolite AMK (N1-acetyl-5-methoxykynuramine) with reactive nitrogen species: Formation of novel compounds, 3-acetamidomethyl-6-methoxycinnolinone and 3-nitro-AMK. J Pineal Res 39(3):251–260

    Article  CAS  PubMed  Google Scholar 

  • Hardeland R (2005) Antioxidative protection by melatonin: multiplicity of mechanisms from radical detoxification to radical avoidance. Endocrine 27(2):119–130

    Article  CAS  PubMed  Google Scholar 

  • Hardeland R (2008) Melatonin, hormone of darkness and more—occurrence, control mechanisms, actions and bioactive metabolites. Cell Mol Life Sci 65(13):2001–2018

    Article  CAS  PubMed  Google Scholar 

  • Hardeland R (2009a) New approaches in the management of insomnia: weighing the advantages of prolonged release melatonin and synthetic melatoninergic agonists. Neuropsychiatr Dis Treat 5:341–354

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hardeland R (2009b) Melatonin, mitochondrial electron flux and leakage: recent findings and resolution of contradictory results. Adv Stud Biol 1(5):207–230

    Google Scholar 

  • Hardeland R (2009c) Neuroprotection by radical avoidance: search for suitable agents. Molecules 14(12):5054–5102

    Article  CAS  PubMed  Google Scholar 

  • Hardeland R (2010) Investigational melatonin receptor agonists. Expert Opin Investig Drugs 19(6):747–764

    Article  CAS  PubMed  Google Scholar 

  • Hardeland R (2011) Melatonin and its metabolites as anti-nitrosating and anti-nitrating agents. J Exp Integ Med 1(2):67–81

    Article  Google Scholar 

  • Hardeland R (2012) Melatonin in aging and disease—multiple consequences of reduced secretion, options and limits of treatment. Aging Dis 3(2):194–225

    PubMed  Google Scholar 

  • Hardeland R (2013a) Melatonin and the theories of aging: a critical appraisal of melatonin’s role in antiaging mechanisms. J Pineal Res 55(4):325–356

    CAS  PubMed  Google Scholar 

  • Hardeland R (2013b) Chronobiology of melatonin beyond the feedback to the suprachiasmatic nucleus—Consequences to melatonin dysfunction. Int J Mol Sci 14(3):5817–5841

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hardeland R (2014a) Melatonin, noncoding RNAs, messenger RNA stability and epigenetics—evidence, hints, gaps and perspectives. Int J Mol Sci 15(10):18221–18252

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Hardeland R (2014b) Agomelatine and the risk of hepatotoxicity. J Symptoms Signs 3:341–346

    Google Scholar 

  • Hardeland R (2016) Melatonin and synthetic melatoninergic agonists in psychiatric and age-associated disorders: successful and unsuccessful approaches. Curr Pharm Des 22(8):1086–1101

    Article  CAS  PubMed  Google Scholar 

  • Hardeland R (2017) Melatonin and the pathologies of weakened or dysregulated circadian oscillators. J Pineal Res 62(1):e12377. doi:10.1111/jpi.12377

  • Hardeland R, Poeggeler B (2008) Melatonin beyond its classical functions. Open Physiol J 1:1–23

    Article  CAS  Google Scholar 

  • Hardeland R, Poeggeler B, Niebergall R, Zelosko V (2003) Oxidation of melatonin by carbonate radicals and chemiluminescence emitted during pyrrole ring cleavage. J Pineal Res 34(1):17–25

    Article  CAS  PubMed  Google Scholar 

  • Hardeland R, Cardinali DP, Srinivasan V, Spence DW, Brown GM, Pandi-Perumal SR (2011) Melatonin—A pleiotropic, orchestrating regulator molecule. Prog Neurobiol 93(3):350–384

    Article  CAS  PubMed  Google Scholar 

  • Hardeland R, Madrid JA, Tan D-X, Reiter RJ (2012) Melatonin, the circadian multioscillator system and health: the need for detailed analyses of peripheral melatonin signaling. J Pineal Res 52(2):139–166

    Article  CAS  PubMed  Google Scholar 

  • Hardeland R, Cardinali DP, Brown GM, Pandi-Perumal SR (2015) Melatonin and brain inflammaging. Prog Neurobiol 127–128:46–63

    Article  PubMed  CAS  Google Scholar 

  • Hatzis G, Ziakas P, Kavantzas N, Triantafyllou A, Sigalas P, Andreadou I, Ioannidis K, Chatzis S, Filis K, Papalampros A, Sigala F (2013) Melatonin attenuates high fat diet-induced fatty liver disease in rats. World J Hepatol 5(4):160–169

    PubMed  PubMed Central  Google Scholar 

  • Hoijman E, Rocha Viegas L, Keller Sarmiento MI, Rosenstein RE, Pecci A (2004) Involvement of Bax protein in the prevention of glucocorticoid-induced thymocytes apoptosis by melatonin. Endocrinology 145(1):418–425

    Article  CAS  PubMed  Google Scholar 

  • Huang L, Zhang C, Hou Y, Laudon M, She M, Yang S, Ding L, Wang H, Wang Z, He P, Yin W (2013) Blood pressure reducing effects of piromelatine and melatonin in spontaneously hypertensive rats. Eur Rev Med Pharmacol Sci 17(18):2449–2456

    CAS  PubMed  Google Scholar 

  • Hwang JW, Yao H, Caito S, Sundar IK, Rahman I (2013) Redox regulation of SIRT1 in inflammation and cellular senescence. Free Radic Biol Med 61:95–110

    Article  CAS  PubMed  Google Scholar 

  • Jiang T, Yu JT, Zhu XC, Tan L (2013) TREM2 in Alzheimer’s disease. Mol Neurobiol 48(1):180–185

    Article  CAS  PubMed  Google Scholar 

  • Jiménez-Ortega V, Cano P, Cardinali DP, Esquifino AI (2009) 24-Hour variation in gene expression of redox pathway enzymes in rat hypothalamus: effect of melatonin treatment. Redox Rep 14(3):132–138

    Article  PubMed  CAS  Google Scholar 

  • Jou MJ (2011) Melatonin preserves the transient mitochondrial permeability transition for protection during mitochondrial Ca2+ stress in astrocyte. J Pineal Res 50(4):427–435

    Article  CAS  PubMed  Google Scholar 

  • Jumnongprakhon P, Govitrapong P, Tocharus C, Tungkum W, Tocharus J (2014) Protective effect of melatonin on methamphetamine-induced apoptosis in glioma cell line. Neurotox Res 25(3):286–294

    Article  CAS  PubMed  Google Scholar 

  • Kandimalla R, Thirumala V, Reddy PH (2017) Is Alzheimer’s disease a type 3 diabetes? A critical appraisal. Biochim Biophys Acta 1863(5):1078–1089

    Google Scholar 

  • Kantar Ş, Türközkan N, Bircan FS, Paşaoğlu ÖT (2015) Beneficial effects of melatonin on serum nitric oxide, homocysteine, and ADMA levels in fructose-fed rats. Pharm Biol 53(7):1035–1041

    Article  CAS  PubMed  Google Scholar 

  • Karasek M, Reiter RJ (2002) Melatonin and aging. Neuroendocrinol Lett 23(Suppl. 1):14–16

    CAS  PubMed  Google Scholar 

  • Kilic U, Kilic E, Reiter RJ, Bassetti CL, Hermann DM (2005) Signal transduction pathways involved in melatonin-induced neuroprotection after focal cerebral ischemia in mice. J Pineal Res 38(1):67–71

    Article  CAS  PubMed  Google Scholar 

  • Kim CH, Kim KH, Yoo YM (2011) Melatonin protects against apoptotic and autophagic cell death in C2C12 murine myoblast cells. J Pineal Res 50(3):241–249

    Article  CAS  PubMed  Google Scholar 

  • Kireev RA, Tresguerres AC, Garcia C, Arriznavarreta C, Vara E, Tresguerres JAF (2008) Melatonin is able to prevent the liver of old castrated female rats from oxidative and pro-inflammatory damage. J Pineal Res 45(4):394–402

    Article  CAS  PubMed  Google Scholar 

  • Kireev RA, Vara E, Viña J, Tresguerres JAF (2014) Melatonin and oestrogen treatments were able to improve neuroinflammation and apoptotic processes in dentate gyrus of old ovariectomized female rats. Age (Dordr) 36(5):9707

    Article  CAS  Google Scholar 

  • Kitagawa A, Ohta Y, Ohashi K (2012) Melatonin improves metabolic syndrome induced by high fructose intake in rats. J Pineal Res 52(4):403–413

    Article  CAS  PubMed  Google Scholar 

  • Kizaki T, Sato S, Shirato K, Sakurai T, Ogasawara J, Izawa T, Ohira Y, Suzuki K, Ohno H (2015) Effect of circadian rhythm on clinical and pathophysiological conditions and inflammation. Crit Rev Immunol 35(4):261–275

    Article  PubMed  Google Scholar 

  • Koh PO (2008a) Melatonin attenuates the cerebral ischemic injury via the MEK/ERK/p90RSK/bad signaling cascade. J Vet Med Sci 70(11):1219–1223

    Article  CAS  PubMed  Google Scholar 

  • Koh PO (2008b) Melatonin attenuates the focal cerebral ischemic injury by inhibiting the dissociation of pBad from 14-3-3. J Pineal Res 44(1):101–106

    CAS  PubMed  Google Scholar 

  • Koh PO (2008c) Melatonin prevents ischemic brain injury through activation of the mTOR/p70S6 kinase signaling pathway. Neurosci Lett 444(1):74–78

    Article  CAS  PubMed  Google Scholar 

  • Koh PO (2008d) Melatonin prevents the injury-induced decline of Akt/forkhead transcription factors phosphorylation. J Pineal Res 45(2):199–203

    Article  CAS  PubMed  Google Scholar 

  • Korkmaz A, Rosales-Corral S, Reiter RJ (2012) Gene regulation by melatonin linked to epigenetic phenomena. Gene 503(1):1–11

    Article  CAS  PubMed  Google Scholar 

  • Koziróg M, Poliwczak AR, Duchnowicz P, Koter-Michalak M, Sikora J, Broncel M (2011) Melatonin treatment improves blood pressure, lipid profile, and parameters of oxidative stress in patients with metabolic syndrome. J Pineal Res 50(3):261–266

    Article  PubMed  CAS  Google Scholar 

  • Kupfer DJ, Spiker DG, Coble PA, Neil JF, Ulrich R, Shaw DH (1981) Sleep and treatment prediction in endogenous depression. Am J Psychiatry 138(4):429–434

    Article  CAS  PubMed  Google Scholar 

  • Lahiri DK (1999) Melatonin affects the metabolism of the β-amyloid precursor protein in different cell types. J Pineal Res 26(3):137–146

    Article  CAS  PubMed  Google Scholar 

  • Lahiri DK, Chen D, Ge Y-W, Bondy SC, Sharman EH (2004) Dietary supplementation with melatonin reduces levels of amyloid beta-peptides in the murine cerebral cortex. J Pineal Res 36(4):224–231

    Article  CAS  PubMed  Google Scholar 

  • Lanoix D, Lacasse AA, Reiter RJ, Vaillancourt C (2012) Melatonin: the smart killer: the human trophoblast as a model. Mol Cell Endocrinol 348(1):1–11

    Article  PubMed  CAS  Google Scholar 

  • Lebailly B, Boitard C, Rogner UC (2015) Circadian rhythm-related genes: implication in autoimmunity and type 1 diabetes. Diabetes Obes Metab 17. Suppl 1:134–138

    Google Scholar 

  • Lee SH, Zabolotny JM, Huang H, Lee H, Kim YB (2016) Insulin in the nervous system and the mind: functions in metabolism, memory, and mood. Mol Metab 5(8):589–601

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Leibowitz A, Peleg E, Sharabi Y, Shabtai Z, Shamiss A, Grossman E (2008) The role of melatonin in the pathogenesis of hypertension in rats with metabolic syndrome. Am J Hypertens 21(3):348–351

    Article  CAS  PubMed  Google Scholar 

  • León J, Macías M, Escames G, Camacho E, Khaldy H, Martín M, Espinosa A, Gallo MA, Acuña-Castroviejo D (2000) Structure-related inhibition of calmodulin-dependent neuronal nitric-oxide synthase activity by melatonin and synthetic kynurenines. Mol Pharmacol 58(5):967–975

    PubMed  Google Scholar 

  • Li W, Wu J, Li Z, Zhou Z, Zheng C, Lin L, Tan B, Huang M, Fan M (2016) Melatonin induces cell apoptosis in Mia PaCa-2 cells via the suppression of nuclear factor-κB and activation of ERK and JNK: A novel therapeutic implication for pancreatic cancer. Oncol Rep 36(5):2861–2867

    CAS  PubMed  Google Scholar 

  • Lin TY, Huang WJ, Wu CC, Lu CW, Wang SJ (2014) Acacetin inhibits glutamate release and prevents kainic-acid-induced neurotoxicity in rats. PLoS ONE 9(2):e88644

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Lin C, Chao H, Li Z, Xu X, Liu Y, Hou L, Liu N, Ji J (2016) Melatonin attenuates traumatic brain injury-induced inflammation: a possible role for mitophagy. J Pineal Res 61(2):177–186

    Article  CAS  PubMed  Google Scholar 

  • Listi F, Candore G, Modica MA, Russo M, Di Lorenzo G, Esposito-Pellitteri M, Colonna-Romano G, Aquino A, Bulati M, Lio D, Franceschi C, Caruso C (2006) A study of serum immunoglobin levels in elderly persons that provides new insights into B cell immunosenescence. Ann NY Acad Sci 1089:487–495

    Article  CAS  PubMed  Google Scholar 

  • López A, García JA, Escames G, Venegas C, Ortíz F, López LC, Acuña-Castroviejo D (2009) Melatonin protects the mitochondria from oxidative damage reducing oxygen consumption, membrane potential, and superoxide anion production. J Pineal Res 46(2):188–198

    Article  PubMed  CAS  Google Scholar 

  • Luchetti F, Canonico B, Betti M, Arcangeletti M, Pilolli F, Piroddi M, Canesi L, Papa S, Galli F (2010) Melatonin signaling and cell protection function. FASEB J 24(10):3603–3624

    Article  CAS  PubMed  Google Scholar 

  • Lyssenko V, Nagorny CL, Erdos MR, Wierup N, Jonsson A, Spégel P, Bugliani M, Saxena R, Fex M, Pulizzi N, Isomaa B, Tuomi T, Nilsson P, Kuusisto J, Tuomilehto J, Boehnke M, Altshuler D, Sundler F, Eriksson JG, Jackson AU, Laakso M, Marchetti P, Watanabe RM, Mulder H, Groop L (2009) Common variant in MTNR1B associated with increased risk of type 2 diabetes and impaired early insulin secretion. Nat Genet 41(1):82–88

    Article  CAS  PubMed  Google Scholar 

  • Macleod MR, O’Collins T, Horky LL, Howells DW, Donnan GA (2005) Systematic review and meta-analysis of the efficacy of melatonin in experimental stroke. J Pineal Res 38(1):35–41

    Article  CAS  PubMed  Google Scholar 

  • Maestroni GJM, Cardinali DP, Esquifino AI, Pandi-Perumal SR (2005) Does melatonin play a disease-promoting role in rheumatoid arthritis? J Neuroimmunol 158(1–2):106–111

    Article  CAS  PubMed  Google Scholar 

  • Maity P, Bindu S, Dey S, Goyal M, Alam A, Pal C, Reiter R, Bandyopadhyay U (2009) Melatonin reduces indomethacin-induced gastric mucosal cell apoptosis by preventing mitochondrial oxidative stress and the activation of mitochondrial pathway of apoptosis. J Pineal Res 46(3):314–323

    Article  CAS  PubMed  Google Scholar 

  • Matsubara E, Bryant-Thomas T, Pacheco Quinto J, Henry TL, Poeggeler B, Herbert D, Cruz-Sanchez F, Chyan YJ, Smith MA, Perry G, Shoji M, Abe K, Leone A, Grundke-Ikbal I, Wilson GL, Ghiso J, Williams C, Refolo LM, Pappolla MA, Chain DG, Neria E (2003) Melatonin increases survival and inhibits oxidative and amyloid pathology in a transgenic model of Alzheimer’s disease. J Neurochem 85(5):1101–1108

    Article  CAS  PubMed  Google Scholar 

  • Mayo JC, Sainz RM, Tan DX, Antolín I, Rodríguez C, Reiter RJ (2005) Melatonin and Parkinson’s disease. Endocrine 27(2):169–178

    Article  CAS  PubMed  Google Scholar 

  • Mazzon E, Esposito E, Crisafulli C, Riccardi L, Muià C, Bella PD, Meli R, Cuzzocrea S (2006) Melatonin modulates signal transduction pathways and apoptosis in experimental colitis. J Pineal Res 41(1):363–373

    Article  CAS  PubMed  Google Scholar 

  • McMullan CJ, Curhan GC, Schernhammer ES, Forman JP (2013) Association of nocturnal melatonin secretion with insulin resistance in nondiabetic young women. Am J Epidemiol 178(2):231–238

    Article  PubMed  PubMed Central  Google Scholar 

  • Messner M, Hardeland R, Rodenbeck A, Huether G (1998) Tissue retention and subcellular distribution of continuously infused melatonin in rats under near physiological conditions. J Pineal Res 25(4):251–259

    Article  CAS  PubMed  Google Scholar 

  • Mishima K, Tozawa T, Satoh K, Matsumoto Y, Hishikawa Y, Okawa M (1999) Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep-waking. Biol Psychiatry 45(4):417–421

    Article  CAS  PubMed  Google Scholar 

  • Mohseni M, Mihandoost E, Shirazi A, Sepehrizadeh Z, Bazzaz JT, Ghazi-Khansari M (2012) Melatonin may play a role in modulation of bax and bcl-2 expression levels to protect rat peripheral blood lymphocytes from gamma irradiation induced apoptosis. Mutat Res 738–739:19–27

    Article  PubMed  CAS  Google Scholar 

  • Mombach JC, Vendrusculo B, Bugs CA (2015) A model for p38MAPK-induced astrocyte senescence. PLoS ONE 10(5):e0125217

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Morales I, Guzmán-Martínet L, Cerda-Troncoso C, Farías GA, Maccioni RB (2014) Neuroinflammation in the pathogenesis of Alzheimer’s disease. A rational framework for the search of novel therapeutic approaches. Front Cell Neurosci 8:112

    Google Scholar 

  • Morrey KM, McLachlan JA, Serkin CD, Bakouche O (1994) Activation of human monocytes by the pineal hormone melatonin. J Immunol 153(6):2671–2680

    CAS  PubMed  Google Scholar 

  • Możdżan M, Możdżan M, Chałubiński M, Wojdan K, Broncel M (2014) The effect of melatonin on circadian blood pressure in patients with type 2 diabetes and essential hypertension. Arch Med Sci 10(4):669–675

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Nakahata Y, Kaluzova M, Grimaldi B, Sahar S, Hirayama J, Chen D, Guarente LP, Sassone-Corsi P (2008) The NAD+-dependent deacetylase SIRT1 modulates CLOCK-mediated chromatin remodeling and circadian control. Cell 134(2):329–340

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Nduhirabandi F, Du Toit EF, Blackhurst D, Marais D, Lochner A (2011) Chronic melatonin consumption prevents obesity-related metabolic abnormalities and protects the heart against myocardial ischemia and reperfusion injury in a prediabetic model of diet-induced obesity. J Pineal Res 50(2):171–182

    CAS  PubMed  Google Scholar 

  • Niranjan R, Nath C, Shukla R (2012) Melatonin attenuated mediators of neuroinflammation and α-7 nicotinic acetylcholine receptor mRNA expression in lipopolysaccharide (LPS) stimulated astrocytoma cells, C6. Free Radic Res 46(9):1167–1177

    Article  CAS  PubMed  Google Scholar 

  • Nomaru H, Sakumi K, Katogi A, Ohnishi YN, Kajitani K, Tsuchimoto D, Nestler EJ, Nakabeppu Y (2014) Fosb gene products contribute to excitotoxic microglial activation by regulating the expression of complement C5a receptors in microglia. Glia 62(8):1284–1298

    Article  PubMed  PubMed Central  Google Scholar 

  • Obayashi K, Saeki K, Tone N, Kurumatani N (2014) Relationship between melatonin secretion and nighttime blood pressure in elderly individuals with and without antihypertensive treatment: a cross-sectional study of the HEIJO-KYO cohort. Hypertens Res 37(10):908–913

    Article  CAS  PubMed  Google Scholar 

  • Olcese JM, Cao C, Mori T, Mamcarz MB, Maxwell A, Runfeldt MJ, Wang L, Zhang C, Lin X, Zhang G, Arendash GW (2009) Protection against cognitive deficits and markers of neurodegeneration by long-term administration of melatonin in a transgenic model of Alzheimer disease. J Pineal Res 47(1):82–96

    Article  CAS  PubMed  Google Scholar 

  • Oster H, Challet E, Ott V, Arvat E, de Kloet ER, Dijk DJ, Lightman S, Vgontzas A, Van Cauter E (2017) The functional and clinical significance of the 24-h rhythm of circulating glucocorticoids. Endocr Rev 38(1):3–45

    Google Scholar 

  • Pandi-Perumal SR, Zisapel N, Srinivasan V, Cardinali DP (2005) Melatonin and sleep in aging population. Exp Gerontol 40(12):911–925

    Article  CAS  PubMed  Google Scholar 

  • Pandi-Perumal SR, Srinivasan V, Maestroni GJM, Cardinali DP, Poeggeler B, Hardeland R (2006) Melatonin: nature’s most versatile biological signal? FEBS J 273(13):2813–2838

    Article  CAS  PubMed  Google Scholar 

  • Pandi-Perumal SR, Trakht I, Srinivasan V, Spence DW, Poeggeler B, Hardeland R, Cardinali DP (2009) The effect of melatonergic and non-melatonergic antidepressants on sleep: weighing the alternatives. World J Biol Psychiatry 10(4 Pt 2):342–354

    Article  PubMed  Google Scholar 

  • Panmanee J, Nopparat C, Chavanich N, Shukla M, Mukda S, Song W, Vincent B, Govitrapong P (2015) Melatonin regulates the transcription of βAPP-cleaving secretases mediated through melatonin receptors in human neuroblastoma SH-SY5Y cells. J Pineal Res 58(2):151–165

    Article  CAS  Google Scholar 

  • Pappolla M, Bozner P, Soto C, Shao H, Robakis NK, Zagorski M, Frangione B, Ghiso J (1998) Inhibition of Alzheimer β-fibrillogenesis by melatonin. J Biol Chem 273(13):7185–7188

    Article  CAS  PubMed  Google Scholar 

  • Pappolla MA, Chyan YJ, Poeggeler B, Bozner P, Ghiso J, LeDoux SP, Wilson GL (1999) Alzheimer β protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin. J Pineal Res 27(4):226–229

    Article  CAS  PubMed  Google Scholar 

  • Pappolla MA, Chyan Y-J, Poeggeler B, Frangione B, Wilson G, Ghiso J, Reiter RJ (2000) An assessment of the antioxidant antiamyloidogenic properties of melatonin: implications for Alzheimer’s disease. J Neural Transm 107(2):203–231

    Article  CAS  PubMed  Google Scholar 

  • Paradies G, Petrosillo G, Paradies V, Reiter RJ, Ruggiero FM (2010) Melatonin, cardiolipin and mitochondrial bioenergetics in health and disease. J Pineal Res 48(4):297–310

    Article  CAS  PubMed  Google Scholar 

  • Pedreañez A, Rincón J, Romero M, Viera N, Mosquera J (2004) Melatonin decreases apoptosis and expression of apoptosis-associated proteins in acute puromycin aminonucleoside nephrosis. Nephrol Dial Transplant 19(5):1098–1105

    Article  PubMed  CAS  Google Scholar 

  • Perlis ML, Giles DE, Buysse DJ, Thase ME, Tu X, Kupfer DJ (1997a) Which depressive symptoms are related to which sleep electroencephalographic variables? Biol Psychiatry 42(10):904–913

    Article  CAS  PubMed  Google Scholar 

  • Perlis ML, Giles DE, Buysse DJ, Tu S, Kupfer DJ (1997b) Self-reported sleep disturbance as a prodromal symptom in recurrent depression. J Affect Disord 42(2–3):209–212

    Article  CAS  PubMed  Google Scholar 

  • Petrosillo G, Fattoretti P, Matera M, Ruggiero FM, Bertoni-Freddari C, Paradies G (2008) Melatonin prevents age-related mitochondrial dysfunction in rat brain via cardiolipin protection. Rejuvenation Res 11(5):935–943

    Article  CAS  PubMed  Google Scholar 

  • Petrosillo G, Moro N, Paradies V, Ruggiero FM, Paradies G (2010) Increased susceptibility to Ca2+-induced permeability transition and cytochrome c release in rat heart mitochondria with aging: effect of melatonin. J Pineal Res 48(4):340–346

    Article  CAS  PubMed  Google Scholar 

  • Pita R, Marco-Contelles J, Ramos E, Del Pino J, Romero A (2013) Toxicity induced by chemical warfare agents: insights on the protective role of melatonin. Chem Biol Interact 206(2):134–142

    Article  CAS  PubMed  Google Scholar 

  • Poeggeler B (2005) Melatonin, aging, and age-related diseases. Endocrine 27(2):201–212

    Article  CAS  PubMed  Google Scholar 

  • Poeggeler B, Miravalle L, Zagorski MG, Wisniewski T, Chyan YJ, Zhang Y, Shao H, Bryant-Thomas T, Vidal R, Frangione B, Ghiso J, Pappolla MA (2001) Melatonin reverses the profibrillogenic activity of apolipoprotein E4 on the Alzheimer amyloid Aβ peptide. Biochemistry 40(49):14995–15001

    Article  CAS  PubMed  Google Scholar 

  • Ponnappan S, Ponnappan U (2011) Aging and immune function: molecular mechanisms to interventions. Antioxid Redox Signal 14(8):1551–1585

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Postuma RB, Berg D (2016) Advances in markers of prodromal Parkinson disease. Nat Rev Neurol 12(11):622–634

    Google Scholar 

  • Quinn J, Kulhanek D, Nowlin J, Jones R, Praticò D, Rokach J, Stackman R (2005) Chronic melatonin therapy fails to alter amyloid burden or oxidative damage in old Tg2576 mice: implications for clinical trials. Brain Res 1037(1–2):209–213

    Article  CAS  PubMed  Google Scholar 

  • Raghavendra V, Singh V, Shaji AV, Vohra H, Kulkarni SK, Agrewala JN (2001) Melatonin provides signal 3 to unprimed CD4+ T cells but failed to stimulate LPS primed B cells. Clin Exp Immunol 124(3):414–422

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Reiter RJ (1995) The pineal gland and melatonin in relation to aging: a summary of the theories and of the data. Exp Gerontol 30(3–4):199–212

    Article  CAS  PubMed  Google Scholar 

  • Reiter RJ (1998) Oxidative damage in the central nervous system: protection by melatonin. Prog Neurobiol 56(3):359–384

    Article  CAS  PubMed  Google Scholar 

  • Reiter RJ, Cabrera J, Sainz RM, Mayo JC, Manchester LC, Tan D-X (1999) Melatonin as a pharmacological agent against neuronal loss in experimental models of Huntington’s disease, Alzheimer’s disease and parkinsonism. Ann NY Acad Sci 890:471–485

    Article  CAS  PubMed  Google Scholar 

  • Reiter RJ, Sainz RM, Lopez-Burillo S, Mayo JC, Manchester LC, Tan D-X (2003) Melatonin ameliorates neurologic damage and neurophysiologic deficits in experimental models of stroke. Ann NY Acad Sci 993:35–47

    Article  CAS  PubMed  Google Scholar 

  • Reiter RJ, Tan D-X, Leon J, Kilic U, Kilic E (2005) When melatonin gets on your nerves: its beneficial actions in experimental models of stroke. Exp Biol Med (Maywood) 230(2):104–117

    Article  CAS  Google Scholar 

  • Reiter RJ, Tan D-X, Manchester LC, Tamura H (2007) Melatonin defeats neurally-derived free radicals and reduces the associated neuromorphological and neurobehavioral damage. J Physiol Pharmacol 58(Suppl6):5–22

    PubMed  Google Scholar 

  • Reiter RJ, Manchester LC, Tan D-X (2010) Neurotoxins: free radical mechanisms and melatonin protection. Curr Neuropharmacol 8(3):194–210

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Rodríguez MI, Escames G, López LC, López A, García JA, Ortiz F, Sánchez V, Romeu M, Acuña-Castroviejo D (2008) Improved mitochondrial function and increased life span after chronic melatonin treatment in senescent prone mice. Exp Gerontol 43(8):749–756

    Article  PubMed  CAS  Google Scholar 

  • Rosales-Corral SA, Acuña-Castroviejo D, Coto-Montes A, Boga JA, Manchester LC, Fuentes-Broto L, Korkmaz A, Ma S, Tan D-X, Reiter RJ (2012) Alzheimer’s disease: pathological mechanisms and the beneficial role of melatonin. J Pineal Res 52(2):167–202

    Article  CAS  PubMed  Google Scholar 

  • Rosen J, Than NN, Koch D, Poeggeler B, Laatsch H, Hardeland R (2006) Interactions of melatonin and its metabolites with the ABTS cation radical: extension of the radical scavenger cascade and formation of a novel class of oxidation products, C2-substituted 3-indolinones. J Pineal Res 41(4):374–381

    Article  CAS  PubMed  Google Scholar 

  • Rubio-Sastre P, Scheer FA, Gomez-Abellan P, Madrid JA, Garaulet M (2014) Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening. Sleep 37(10):1715–1719

    Article  PubMed  PubMed Central  Google Scholar 

  • Sainz RM, Mayo JC, Rodriguez C, Tan D-X, Lopez-Burillo S, Reiter RJ (2003) Melatonin and cell death: differential actions on apoptosis in normal and cancer cells. Cell Mol Life Sci 60(7):1407–1426

    Article  CAS  PubMed  Google Scholar 

  • Salameh TS, Rhea EM, Banks WA, Hanson AJ (2016) Insulin resistance, dyslipidemia, and apolipoprotein E interactions as mechanisms in cognitive impairment and Alzheimer’s disease. Exp Biol Med (Maywood). 241(15):1676–1683

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Salminen A, Ojala J, Kaamiranta K, Haapasalo A, Hiltunen M, Soininen H (2011) Astrocytes in the aging brain express characteristics of senescence-associated secretory phenotype. Eur J Neurosci 34(1):3–11

    Article  PubMed  Google Scholar 

  • Sánchez-Hidalgo M, Guerrero JM, Villegas I, Packham G, de la Lastra CA (2012) Melatonin, a natural programmed cell death inducer in cancer. Curr Med Chem 19(22):3805–3821

    Article  PubMed  Google Scholar 

  • Scheer FA, Van Montfrans GA, van Someren EJ, Mairuhu G, Buijs RM (2004) Daily nighttime melatonin reduces blood pressure in male patients with essential hypertension. Hypertension 43(2):192–197

    Article  CAS  PubMed  Google Scholar 

  • Shinozuka K, Staples M, Borlongan CV (2013) Melatonin-based therapeutics for neuroprotection in stroke. Int J Mol Sci 14(5):8924–8947

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Shukla M, Htoo HH, Wintachai P, Hernandez JF, Dubois C, Postina R, Xu H, Checler F, Smith DR, Govitrapong P, Vincent B (2015) Melatonin stimulates the nonamyloidogenic processing of βAPP through the positive transcriptional regulation of ADAM10 and ADAM17. J Pineal Res 58(2):151–165

    Article  CAS  PubMed  Google Scholar 

  • Singer C, Tractenberg RE, Kaye J, Schafer K, Gamst A, Grundman M, Thomas R, Thal LJ, Alzheimer’s Disease Cooperative Study (2003) A multicenter, placebo-controlled trial of melatonin for sleep disturbance in Alzheimer’s disease. Sleep 26(7):893–901

    Google Scholar 

  • Singhal NK, Srivastava G, Agrawal S, Jain SK, Singh MP (2012) Melatonin as a neuroprotective agent in the rodent models of Parkinson’s disease: is it all set to irrefutable clinical translation? Mol Neurobiol 45(1):186–199

    Article  CAS  PubMed  Google Scholar 

  • Skaper SD, Floreani M, Ceccon M, Facci L, Giusti P (1999) Excitotoxicity, oxidative stress, and the neuroprotective potential of melatonin. Ann NY Acad Sci 890:107–118

    Article  CAS  PubMed  Google Scholar 

  • Skene DJ, Arendt J (2006) Human circadian rhythms: physiological and therapeutic relevance of light and melatonin. Ann Clin Biochem 43(Pt 5):344–353

    Article  CAS  PubMed  Google Scholar 

  • Sobolewska-Włodarczyk A, Włodarczyk M, Szemraj J, Stec-Michalska K, Fichna J, Wiśniewska-Jarosińska M (2016) Circadian rhythm abnormalities—association with the course of inflammatory bowel disease. Pharmacol Rep 68(4):847–851

    Article  PubMed  Google Scholar 

  • Song W, Lahiri DK (1997) Melatonin alters the metabolism of the β-amyloid precursor protein in the neuroendocrine cell line PC12. J Mol Neurosci 9(2):75–92

    Article  CAS  PubMed  Google Scholar 

  • Srinivasan V, Pandi-Perumal SR, Cardinali DP, Poeggeler B, Hardeland R (2006) Melatonin in Alzheimer’s disease and other neurodegenerative disorders. Behav Brain Funct 2:15

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Srinivasan V, Pandi-Perumal SR, Trakht I, Spence DW, Hardeland R, Poeggeler B, Cardinali DP (2009) Pathophysiology of depression: role of sleep and the melatonergic system. Psychiatry Res 165(3):201–214

    Article  CAS  PubMed  Google Scholar 

  • Srinivasan V, Cardinali DP, Srinivasan US, Kaur C, Brown GM, Spence DW, Hardeland R, Pandi-Perumal SR (2011) Therapeutic potential of melatonin and its analogs in Parkinson’s disease: focus on sleep and neuroprotection. Ther Adv Neurol Disord 4(5):297–317

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Stehle JH, von Gall C, Korf HW (2003) Melatonin: a clock-output, a clock-input. J Neuroendocrinol 15(4):383–389

    Article  CAS  PubMed  Google Scholar 

  • Strindhall J, Nilsson BO, Löfgren S, Ernerudh J, Pawelec G, Johansson B, Wikby A (2007) No Immune Risk Profile among individuals who reach 100 years of age: findings from the Swedish NONA immune longitudinal study. Exp Gerontol 42(8):753–761

    Article  CAS  PubMed  Google Scholar 

  • Tajes M, Gutierrez-Cuesta J, Ortuño-Sahagun D, Camins A, Pallàs M (2009) Anti-aging properties of melatonin in an in vitro murine senescence model: involvement of the sirtuin 1 pathway. J Pineal Res 47(3):228–237

    Article  CAS  PubMed  Google Scholar 

  • Takeuchi H, Mizuno T, Zhang G, Wang J, Kawanokuchi J, Kuno R, Suzumura A (2005) Neuritic beading induced by activated microglia is an early feature of neuronal dysfunction toward neuronal death by inhibition of mitochondrial respiration and axonal transport. J Biol Chem 280(11):10444–10454

    Article  CAS  PubMed  Google Scholar 

  • Tan D-X, Chen L-D, Poeggeler B, Manchester LC, Reiter RJ (1993) Melatonin: a potent, endogenous hydroxyl radical scavenger. Endocr J 1(4):57–60

    Google Scholar 

  • Tapias V, Escames G, López LC, López A, Camacho E, Carrión MD, Entrena A, Gallo MA, Espinosa A, Acuña-Castroviejo D (2009) Melatonin and its brain metabolite N1-acetyl-5-methoxykynuramine prevent mitochondrial nitric oxide synthase induction in parkinsonian mice. J Neurosci Res 87(13):3002–3010

    Article  CAS  PubMed  Google Scholar 

  • Tilleux S, Hermans E (2007) Neuroinflammation and regulation of glial glutamate uptake in neurological disorders. J Neurosci Res 85(10):2059–2070

    Article  CAS  PubMed  Google Scholar 

  • Tocharus J, Chongthammakun S, Govitrapong P (2008) Melatonin inhibits amphetamine-induced nitric oxide synthase mRNA overexpression in microglial cell lines. Neurosci Lett 439(2):134–137

    Article  CAS  PubMed  Google Scholar 

  • Trufakin VA, Shurlygina AV (2016) Circadian rhythm in cytokines administration. Mini Rev Med Chem 16(1):55–66

    Article  CAS  PubMed  Google Scholar 

  • Tuñón MJ, San Miguel B, Crespo I, Jorquera F, Santamaría E, Alvarez M, Prieto J, González-Gallego J (2011) Melatonin attenuates apoptotic liver damage in fulminant hepatic failure induced by the rabbit hemorrhagic disease virus. J Pineal Res 50(1):38–45

    Article  PubMed  CAS  Google Scholar 

  • Tuomi T, Nagorny CL, Singh P, Bennet H, Yu Q, Alenkvist I, Isomaa B, Östman B, Söderström J, Pesonen AK, Martikainen S, Räikkönen K, Forsén T, Hakaste L, Almgren P, Storm P, Asplund O, Shcherbina L, Fex M, Fadista J, Tengholm A, Wierup N, Groop L, Mulder H (2016) Increased melatonin signaling is a risk factor for type 2 diabetes. Cell Metab 23(6):1067–1077

    Article  CAS  PubMed  Google Scholar 

  • Uguz AC, Cig B, Espino J, Bejarano I, Naziroglu M, Rodríguez AB, Pariente JA (2012) Melatonin potentiates chemotherapy-induced cytotoxicity and apoptosis in rat pancreatic tumor cells. J Pineal Res 53(1):91–98

    Article  CAS  PubMed  Google Scholar 

  • Venegas C, García JA, Escames G, Ortiz F, López A, Doerrier C, García-Corzo L, López LC, Reiter RJ, Acuña-Castroviejo D (2012) Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations. J Pineal Res 52(2):217–227

    Article  CAS  PubMed  Google Scholar 

  • Verdile G, Keane KN, Cruzat VF, Medic S, Sabale M, Rowles J, Wijesekara N, Martins RN, Fraser PE, Newsholme P (2015) Inflammation and oxidative stress: the molecular connectivity between insulin resistance, obesity, and Alzheimer’s disease. Mediators Inflamm 2015:105828

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  • Vinogradova I, Anisimov V (2013) Melatonin prevents the development of the metabolic syndrome in male rats exposed to different light/dark regimens. Biogerontology 14(4):401–409

    Article  CAS  PubMed  Google Scholar 

  • Wang X (2009) The antiapoptotic activity of melatonin in neurodegenerative diseases. CNS Neurosci Ther 15(4):345–357

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Wang S, Zhu L, Shi H, Zheng H, Tian Q, Wang Q, Liu R, Wang JZ (2007) Inhibition of melatonin biosynthesis induced neurofilament hyperphosphorylation with activation of cyclin-dependent kinase 5. Neurochem Res 32(8):1329–1335

    Article  CAS  PubMed  Google Scholar 

  • Watson N, Diamandis T, Gonzales-Portillo C, Reyes S, Borlongan CV (2016) Melatonin as an antioxidant for stroke neuroprotection. Cell Transplant 25(5):883–891

    Article  PubMed  Google Scholar 

  • Willis GL (2005) The role of ML-23 and other melatonin analogues in the treatment and management of Parkinson’s disease. Drug News Perspect 18(7):437–444

    Article  CAS  PubMed  Google Scholar 

  • Willis GL (2008) Parkinson’s disease as a neuroendocrine disorder of circadian function: dopamine-melatonin imbalance and the visual system in the genesis and progression of the degenerative process. Rev Neurosci 19(4–5):245–316

    CAS  PubMed  Google Scholar 

  • Yamazaki S, Straume M, Tei H, Sakaki Y, Menaker M, Block GD (2002) Effects of aging on central and peripheral mammalian clocks. Proc Natl Acad Sci USA 99(16):10801–10806

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  • Young ARJ, Narita M (2009) SASP reflects senescence. EMBO Rep 10(3):228–230

    Article  CAS  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Johann Friedrich Blumenbach Institute of Zoology and Anthropology, University of Göttingen, Göttingen, Germany

    Rüdiger Hardeland

Authors
  1. Rüdiger Hardeland
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Rüdiger Hardeland .

Editor information

Editors and Affiliations

  1. Department of Molecular Biology and Genetics, Aarhus University, Aarhus, Denmark

    Suresh Rattan

  2. Department of Biochemistry, North Eastern Hill University, Shillong, Megalaya, India

    Ramesh Sharma

Rights and permissions

Reprints and permissions

Copyright information

© 2017 Springer International Publishing AG

About this chapter

Cite this chapter

Hardeland, R. (2017). Melatonin in Healthy Aging and Longevity. In: Rattan, S., Sharma, R. (eds) Hormones in Ageing and Longevity. Healthy Ageing and Longevity, vol 6. Springer, Cham. https://doi.org/10.1007/978-3-319-63001-4_10

Download citation

Publish with us

Policies and ethics

Search

Navigation